MIF-Dgradation (Apaxen)

N/A

Report date: 2024/12/05 15:01:42
NMEFirst In Class

Base Information

Drug NameMIF-Dgradation (Apaxen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage migration inhibitory factor degraders
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApaxen SA
China Registration ClassN/A

Develop Information

Active CompaniesApaxen SA
Inactive CompaniesN/A
Active IndicationsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A